PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: ...

Procept BioRobotics anticipates sharing the primary endpoint results from WATER IV in 2027.

PROCEPT BioRobotics recently reported two major milestones in its WATER IV prostate cancer program, completing enrollment in the randomized WATER IV RP trial comparing Aquablation therapy with radical ...

Procept BioRobotics (Nasdaq:PRCT) announced that it received FDA investigational device exemption (IDE) for a second ...

Before having Aquablation (water ablation) therapy, it is essential to check that the treatment, equipment, medical facility, and healthcare professional are Medicare-approved and that the person ...

UVA Health Prince William Medical Center has begun offering Aquablation therapy, an advanced AI-powered treatment for benign ...

Siemens Healthineers’ MRI scanners would guide robotic neurosurgeries performed with AiM’s platform. Elsewhere, Procept ...

For men with benign prostate hyperplasia, aquablation provides temporary benefits for ejaculation and continence at three months, while holmium laser enucleation of the prostate (HoLEP) has superior ...

For 69-year-old Andre Price, living with an enlarged prostate was affecting every part of his life. "I was getting up every hour and a half," Price says of having to wake frequently to use the ...

For an estimated one in two men aged 51 to 60, benign prostatic hyperplasia (BPH), or an enlarged prostate, is the number one reason they visit the urologist. Risk factors for BPH include aging, ...

Two interventions to treat large prostates produced similar symptom relief but had different effects on prostate volume and different adverse event profiles, a large randomized trial showed. Baseline ...

Men with larger vs smaller prostate gland sizes treated with Aquablation experienced similar improvement in International Prostate Symptom Score. The following article features coverage from the ...